health
U.S. Government Claims Ownership of Key H.I.V. Prevention Drugs in Patent Dispute With Pharma Giant
In a landmark legal and ethical challenge, the U.S. government asserts that it holds the patent rights to PrEP, a life-saving HIV prevention method, arguing that taxpayer-funded research laid the foundation for the drug's development. The move has sparked fierce debate over drug pricing, access, and pharmaceutical accountability.
By Roy J. Miles
Read More